143 related articles for article (PubMed ID: 37752563)
1. Serum metabolite profiling reveals metabolic characteristics of sepsis patients using LC/MS-based metabolic profiles: a cross-sectional study.
Peng J; Qiu C; Zhang J; Xiao X
BMC Med Genomics; 2023 Sep; 16(1):224. PubMed ID: 37752563
[TBL] [Abstract][Full Text] [Related]
2. Discrimination of serum metabolomics profiles in infants with sepsis, based on liquid chromatography-mass spectrometer.
Wang L; Cha X; Zhang Z; Qian J
BMC Infect Dis; 2023 Jan; 23(1):46. PubMed ID: 36690951
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
Zhang J; Bowers J; Liu L; Wei S; Gowda GA; Hammoud Z; Raftery D
PLoS One; 2012; 7(1):e30181. PubMed ID: 22291914
[TBL] [Abstract][Full Text] [Related]
4. A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes.
Chang Y; Yoo HJ; Kim SJ; Lee K; Lim CM; Hong SB; Koh Y; Huh JW
Crit Care; 2023 Jul; 27(1):263. PubMed ID: 37408042
[TBL] [Abstract][Full Text] [Related]
5. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
6. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
7. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
8. [Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].
Wu WJ; Wang Q; Zhang W; Li L
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):896-902. PubMed ID: 29262505
[No Abstract] [Full Text] [Related]
9. Identification of potential serum metabolic biomarkers for patient with keratoconus using untargeted metabolomics approach.
Daphne Teh AL; Jayapalan JJ; Loke MF; Wan Abdul Kadir AJ; Subrayan V
Exp Eye Res; 2021 Oct; 211():108734. PubMed ID: 34428458
[TBL] [Abstract][Full Text] [Related]
10. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
Lindahl A; Forshed J; Nordström A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
[TBL] [Abstract][Full Text] [Related]
11. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors.
Liu Z; Yin P; Amathieu R; Savarin P; Xu G
Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981
[TBL] [Abstract][Full Text] [Related]
12. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
Shen W; Han W; Li Y; Meng Z; Cai L; Li L
Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
Khamis MM; Adamko DJ; El-Aneed A
Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
[TBL] [Abstract][Full Text] [Related]
14. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry for the discovery of biomarkers of sepsis.
Ludwig KR; Hummon AB
Mol Biosyst; 2017 Mar; 13(4):648-664. PubMed ID: 28207922
[TBL] [Abstract][Full Text] [Related]
16. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
[TBL] [Abstract][Full Text] [Related]
17. Untargeted Metabolomic Profiling of Cuprizone-Induced Demyelination in Mouse Corpus Callosum by UPLC-Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders.
Zhao Z; Li T; Dong X; Wang X; Zhang Z; Zhao C; Kang X; Zheng R; Li X
Oxid Med Cell Longev; 2021; 2021():7093844. PubMed ID: 34567412
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis.
Chen DY; Chen YM; Chien HJ; Lin CC; Hsieh CW; Chen HH; Hung WT; Lai CC
PLoS One; 2016; 11(12):e0168147. PubMed ID: 28005947
[TBL] [Abstract][Full Text] [Related]
19. Joint MS-based platforms for comprehensive comparison of rat plasma and serum metabolic profiling.
Lin Z; Zhang Z; Lu H; Jin Y; Yi L; Liang Y
Biomed Chromatogr; 2014 Sep; 28(9):1235-45. PubMed ID: 24619916
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
